Controlling and Lowering Blood Pressure With The MOBIUSHD™

Completed · Not applicable

Conditions studied: Hypertension

In brief

To evaluate the safety and performance of the MobiusHD system in subjects with resistant hypertension.

Key facts

Study ID

NCT01831895

Run by

Vascular Dynamics, Inc.

People needed

17

Starts

2013-05-01

Expected to finish

2021-04-13

Last updated by the study team

2023-05-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Office cuff SBP ≥ 160 mmHg measured per protocol instructions (Appendix IV) following at least one (1) month of maximally tolerated therapy with at least three (3) anti-hypertensive medications, of which at least one (1) must be a diuretic. Any combination medications will be counted per the active ingredient. (For example, Zestoretic (Lisinopril +HCTZ) equals two (2) anti-hypertensive medications)

You may not qualify if…

• Known or clinically suspected baroreflex failure or autonomic neuropathy

Where it is running

• Cardiology, P.C. — Birmingham, Alabama, United States
• Emory University — Atlanta, Georgia, United States
• Iowa Heart Center — Des Moines, Iowa, United States
• Ochsner Clinic Foundation — New Orleans, Louisiana, United States
• University of Rochester — Rochester, New York, United States
• The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital — Cincinnati, Ohio, United States
• Turkey Creek Medical Center — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.